mitoxantrone has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 3 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Alvi, SB | 1 |
| Rajalakshmi, PS | 1 |
| Jogdand, AB | 1 |
| Nazia, B | 1 |
| Bantal, V | 1 |
| Rengan, AK | 1 |
| Chen, Z | 1 |
| Li, S | 1 |
| Li, F | 1 |
| Qin, C | 1 |
| Li, X | 1 |
| Qing, G | 1 |
| Wang, J | 1 |
| Xia, B | 1 |
| Zhang, F | 1 |
| Meng, L | 1 |
| Liang, XJ | 1 |
| Xiao, Y | 1 |
| Toh, TB | 1 |
| Lee, DK | 1 |
| Hou, W | 1 |
| Abdullah, LN | 1 |
| Nguyen, J | 1 |
| Ho, D | 1 |
| Chow, EK | 1 |
3 other studies available for mitoxantrone and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Chitosan IR806 dye-based polyelectrolyte complex nanoparticles with mitoxantrone combination for effective chemo-photothermal therapy of metastatic triple-negative breast cancer.
Topics: Cell Line, Tumor; Chitosan; Doxorubicin; Humans; Hyperthermia, Induced; Mitoxantrone; Nanoparticles; | 2022 |
DNA Damage Inducer Mitoxantrone Amplifies Synergistic Mild-Photothermal Chemotherapy for TNBC via Decreasing Heat Shock Protein 70 Expression.
Topics: HSP70 Heat-Shock Proteins; Humans; Micelles; Mitoxantrone; Phototherapy; Triple Negative Breast Neop | 2023 |
Nanodiamond-mitoxantrone complexes enhance drug retention in chemoresistant breast cancer cells.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette | 2014 |